Sterling Capital Management
GLSI icon

Sterling Capital Management’s Greenwich LifeSciences GLSI Stock Holding History

Sterling Capital Management’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.99K Buy
221
+197
+821% +$3.28K ﹤0.01% 2955
2026
Q2 		$563 Sell
24
-16
-40% -$389 ﹤0.01% 3213
2026
Q1 		$961 Hold
40
– – ﹤0.01% 3102
2025
Q4 		$840 Buy
40
+25
+167% +$263 ﹤0.01% 3152
2025
Q3 		$149 Buy
15
+1
+7% +$11 ﹤0.01% 3228
2025
Q2 		$127 Buy
14
+8
+133% +$76 ﹤0.01% 3247
2025
Q1 		$57 Hold
6
– – ﹤0.01% 3173
2024
Q4 		$67 Hold
6
– – ﹤0.01% 3197
2024
Q3 		$86 Buy
+6
New +$89 ﹤0.01% 3204

Other funds holding GLSI

STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
North Star Investment Management
North Star Investment Management Chicago, Illinois $1.85B AUM 21.53% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
SJS Investment Consulting
SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Sterling Capital Management's GLSI Position: Q3 2026 in Review

Sterling Capital Management increased its Greenwich LifeSciences (GLSI) stake by 821% in Q3 2026, buying an estimated $3.28K and bringing the position to 221 shares worth $3.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2955.

Sterling Capital Management first reported a position in GLSI in Q3 2024 and has held it in 9 quarters since. 9 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

  • Sterling Capital Management held 221 shares of Greenwich LifeSciences worth $3.99K as of Q3 2026.
  • Sterling Capital Management bought 197 Greenwich LifeSciences shares in Q3 2026, an estimated $3.28K.
  • Greenwich LifeSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2955 holding.
  • Sterling Capital Management first reported a position in Greenwich LifeSciences in Q3 2024 and has held it in 9 quarters since.
  • 9 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.